NASDAQ:BIOL BIOLASE 5/13/2024 Earnings Report Profile BIOLASE EPS ResultsActual EPS-$0.36Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/ABIOLASE Revenue ResultsActual Revenue$10.13 millionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/ABIOLASE Announcement DetailsQuarterDate5/13/2024TimeN/AConference Call DateN/AConference Call TimeN/AConference Call ResourcesCompany Profile BIOLASE Earnings HeadlinesBIOLASE Showcases Advanced YSGG Laser Solutions for Periodontal and Implant Care at GNYDM 2025November 25, 2025 | finance.yahoo.comBIOLASE Showcases Breakthrough YSGG Laser Protocol for Predictable Periodontitis Treatment at AAP 2025October 14, 2025 | prnewswire.com$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s known for playing his cards “close to the vest”… Is going to give you the name and ticker symbol of a company he believes will skyrocket thanks to the coming Starlink IPO…June 1 at 1:00 AM | Paradigm Press (Ad)BIOLASE MG LLC: BIOLASE Emerges Stronger Than Ever Under New Ownership by MegaGen ImplantSeptember 10, 2025 | finanznachrichten.deBIOLASE Emerges Stronger Than Ever Under New Ownership by MegaGen ImplantSeptember 10, 2025 | prnewswire.comBiolase Inc (BIOLQ)December 12, 2024 | finance.yahoo.comSee More BIOLASE Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like BIOLASE? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BIOLASE and other key companies, straight to your email. Email Address About BIOLASEBIOLASE (NASDAQ:BIOL) (NASDAQ: BIOL) is a medical device company specializing in the design, development and manufacture of laser systems for dentistry. The company’s laser platforms enable minimally invasive dental procedures, combining laser energy with water spray to perform both hard‐tissue and soft‐tissue applications. By integrating advanced laser technology into routine dental care, BIOLASE aims to improve patient comfort, reduce the need for anesthesia and shorten procedure times. The company’s flagship products include the Waterlase® family of erbium lasers and the Epic™ series of diode lasers. Waterlase systems are indicated for a wide range of applications, including cavity preparation, bone surgery, endodontics, periodontal therapy and oral surgery. Epic diode lasers are used primarily for soft‐tissue procedures such as gum recontouring, pain management and bacterial reduction. BIOLASE also offers a comprehensive portfolio of handpieces, tips and accessories to support clinical workflows and practice growth. Founded in 1984 and headquartered in Irvine, California, BIOLASE has established a global distribution network that spans North America, Europe, Asia and other international markets. The company works with dental equipment dealers, group purchasing organizations and strategic partners to expand market reach and provide training and support to dental professionals. BIOLASE’s research and development efforts are focused on enhancing laser performance, broadening procedural indications and integrating digital dentistry solutions.View BIOLASE ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 05/25 - 05/29Gap Inc. Cuts Sales Outlook After Q1 Miss, Shares Drop 17%Costco’s Strong Quarter Still Leaves Investors With a Valuation ProblemMongoDB's AI Advantage Is Starting to Show Up in ResultsShares Fall, Targets Rise—Markets and Analysts Diverge on SynopsysBest Buy’s AI Laptop Boost Sparks Hope for a BBY TurnaroundWas Hormel’s Q2 Earnings Report the Turnaround Investors Needed? Upcoming Earnings Palo Alto Networks (6/2/2026)Broadcom (6/3/2026)CrowdStrike (6/3/2026)Medtronic (6/3/2026)Ciena (6/4/2026)Oracle (6/10/2026)Adobe (6/11/2026)Accenture (6/18/2026)FedEx (6/23/2026)Micron Technology (6/24/2026) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
